SEC FORM 4
$81,500.00
Estrella Immunopharma, Inc. (ESLA)
Acquisition (code M) of 100,000 shares at $0.815 per share.
Reporting Person Xu Jiandong · Officer Title Chief Financial Officer · Transaction Code M
Traded Aug 18, 2026 · Disclosed Aug 25, 2026FILED +7 DAYS
Source: SEC Form 4 · 0001213900-26-093698 · filed 2026-08-25 · View filing →